Extranodal NK/T-Cell Lymphoma, Nasal Type Yexiong Li, 2017, Radiation Therapy in Hematologic Malignancies CrossRef
Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis
Jin Li et al, 2020, Therapeutics and Clinical Risk Management CrossRef
Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder Tracy T. Batchelor et al, 2016, American Society of Clinical Oncology Educational Book CrossRef
Defining the toxicity of current regimens for extranodal NK/T cell lymphoma: a systematic review and metaproportion Vadim S. Pokrovsky et al, 2019, Expert Review of Anticancer Therapy CrossRef
Sequential DICE combined withl-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma Li-Hua Dong et al, 2016, Leukemia & Lymphoma CrossRef
Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study Yong Yang et al, 2015, Blood CrossRef
Peripheral T cell lymphoma coexisting with Castleman's disease Shuyan Liu et al, 2020, Medicine CrossRef
Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma Jing-hua Wang et al, 2016, Oncotarget CrossRef
Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study Ji‐Wei Li et al, 2018, European Journal of Haematology CrossRef
First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG Shu-Nan Qi et al, 2020, Blood Advances CrossRef